Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Fischereder

Showing results (21-30 of 111) with videos related to

Pageof 12
Sort By:
Deutsche Medizinische Wochenschrift (1946)|June 20, 2020
[Onconephrology - Interdisciplinary Cooperation of Nephrologists and Oncologists in the Treatment of Multiple Myeloma]Ulf Schönermarck, Marcus Hentrich, Florian Bassermann, et al.
Deutsche Medizinische Wochenschrift (1946)|July 28, 2019
[Prevention of "contrast-induced" acute kidney injury - practical considerations]Marc Weidenbusch, Markus Wörnle, Philipp Kazmierczak, et al.
The Lancet Regional Health. Europe|November 1, 2021
Humoral immunity to SARS-CoV-2 vaccination in haemodialysis patients: (Response to: Humoral and cellular immunity to SARS-CoV-2 vaccination in renal transplant versus dialysis patients: A prospective, multicenter observational study using mRNA-1273 or BNT162b2 mRNA vaccine.)Sandra Hasmann, Michael Paal, Louise Füeßl, et al.
Kidney International|June 8, 2020
Cyclosporine as a preferred calcineurin inhibitor in renal allograft recipients with COVID-19 infectionStephan Kemmner, Markus O Guba, Ulf Schönermarck, et al.
MMW Fortschritte Der Medizin|January 10, 2013
[Nephron-sparing treatments for kidney cancer]Jozefina Casuscelli, Michael Fischereder, Christian Gratzke, et al.
Transplantation|March 30, 2002
Tacrolimus-induced nephrotoxicity unmasked by induction of the CYP3A4 system with St John's wortRenate Bolley, Carl Zülke, Martin Kammerl, et al.
GMS Health Technology Assessment|February 4, 2011
Antioxidative vitamines for prevention of cardiovascular disease for patients after renal transplantation and patients with chronic renal failurePetra Schnell-Inderst, Beate Kossmann, Michael Fischereder, et al.
Lancet (London, England)|March 28, 2003
The COOPERATE trialBernd Krüger, Carsten Böger, Mike Stubanus, et al.
Journal of the American Society of Nephrology : JASN|January 30, 2004
The value of N-acetylcysteine in the prevention of radiocontrast agent-induced nephropathy seems questionableUte Hoffmann, Michael Fischereder, Bernd Krüger, et al.
Therapeutic Drug Monitoring|May 22, 2025
An Offline SPE-LC-MS/MS Method for Simultaneous Quantification of Tacrolimus, Cyclosporine A, Kynurenine, Tryptophan, and Creatinine Using Volumetric Absorptive Microsampling Device MitraKajetan Nierychlewski, Katharina Habler, Stephan Kemmner, et al.
Pageof 12

Showing results (21-30 of 111) with videos related to

Sort By:
Pageof 12
Deutsche Medizinische Wochenschrift (1946)|June 20, 2020
[Onconephrology - Interdisciplinary Cooperation of Nephrologists and Oncologists in the Treatment of Multiple Myeloma]Ulf Schönermarck, Marcus Hentrich, Florian Bassermann, et al.
Deutsche Medizinische Wochenschrift (1946)|July 28, 2019
[Prevention of "contrast-induced" acute kidney injury - practical considerations]Marc Weidenbusch, Markus Wörnle, Philipp Kazmierczak, et al.
The Lancet Regional Health. Europe|November 1, 2021
Humoral immunity to SARS-CoV-2 vaccination in haemodialysis patients: (Response to: Humoral and cellular immunity to SARS-CoV-2 vaccination in renal transplant versus dialysis patients: A prospective, multicenter observational study using mRNA-1273 or BNT162b2 mRNA vaccine.)Sandra Hasmann, Michael Paal, Louise Füeßl, et al.
Kidney International|June 8, 2020
Cyclosporine as a preferred calcineurin inhibitor in renal allograft recipients with COVID-19 infectionStephan Kemmner, Markus O Guba, Ulf Schönermarck, et al.
MMW Fortschritte Der Medizin|January 10, 2013
[Nephron-sparing treatments for kidney cancer]Jozefina Casuscelli, Michael Fischereder, Christian Gratzke, et al.
Transplantation|March 30, 2002
Tacrolimus-induced nephrotoxicity unmasked by induction of the CYP3A4 system with St John's wortRenate Bolley, Carl Zülke, Martin Kammerl, et al.
GMS Health Technology Assessment|February 4, 2011
Antioxidative vitamines for prevention of cardiovascular disease for patients after renal transplantation and patients with chronic renal failurePetra Schnell-Inderst, Beate Kossmann, Michael Fischereder, et al.
Lancet (London, England)|March 28, 2003
The COOPERATE trialBernd Krüger, Carsten Böger, Mike Stubanus, et al.
Journal of the American Society of Nephrology : JASN|January 30, 2004
The value of N-acetylcysteine in the prevention of radiocontrast agent-induced nephropathy seems questionableUte Hoffmann, Michael Fischereder, Bernd Krüger, et al.
Therapeutic Drug Monitoring|May 22, 2025
An Offline SPE-LC-MS/MS Method for Simultaneous Quantification of Tacrolimus, Cyclosporine A, Kynurenine, Tryptophan, and Creatinine Using Volumetric Absorptive Microsampling Device MitraKajetan Nierychlewski, Katharina Habler, Stephan Kemmner, et al.
Pageof 12